Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
87.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (5.882%)
Market Cap: £5.75m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Technology provider for study on ageing

7 Apr 2010 07:00

RNS Number : 7582J
Crimson Tide PLC
07 April 2010
 



Crimson Tide Plc

("Crimson Tide" or the "Company")

CRIMSON TIDE TECHNOLOGY KEEPS IRISH GOVERNMENT PROJECT SECURE

Crimson Tide, the mobile software technologies company, is pleased to announce that a ten year study initiated by the Irish Government to ensure that the needs of its older people are met, is utilising an advanced mobile system developed by the Company to guarantee security and confidentiality.

 TILDA (The Irish LongituDinal Study on Ageing) was launched by Minister for Health Mary Harney in November 2006, to study a representative sample of at least 8,000 people, aged 50 years and over and resident in Ireland. It charts their health, social and economic circumstances over a 10-year period.

The study is being carried out across the whole of Ireland by Trinity College Dublin in collaboration with a panel of scientific researchers and international scientists with expertise in various fields of ageing. Crimson Tide's system ensures this operation is carried out in a secure and confidential manner using mobile portable technology. 

The application is centred around the Motorola MC55 hand held device and requires the user to identify and capture each respondent's details. It enables the user to move through a series of screens, adding additional data relevant to the project, as they proceed. 

 The system uses real time GPRS data transfer to ensure that records are updated immediately after each visit, and the hand held device interacts with a number of application-based tests carried out on a laptop computer. All information gathered is kept strictly confidential and used only for research purposes.

Says Dr Hilary Cronin, Medical Director for TILDA: "Crimson Tide is an exceptional company to work with and I cannot recommend them highly enough. Their people are incredibly efficient and so pleasant to deal with. They spent time ensuring that our technology interfaces were user friendly and intuitive. Our initially 'techno-phobic' research nurses now love their PDA's and can't imagine collecting data without them! It has significantly improved the way we conduct our clinical research. Their technologies are now an integral part of our study and I look forward to working with them again in the future."

Crimson Tide Director Laurence Darcy says: "It has been a privilege to work on this study with Trinity College Dublin to develop a state-of-the art mobile data solution. We are working on a range of solutions in the healthcare sector and expect to have more innovative solutions coming to the market this year."

- ends -

For further information, contact:

Crimson Tide plc

Barrie Whipp, Executive Chairman

 

01892 542 444

Threadneedle Communications

Graham Herring/Josh Royston

 

020 7653 9850

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAXQLFBBZFXBBD
Date   Source Headline
18th Nov 20169:45 amRNSDirector/PDMR Shareholding
13th Oct 20167:00 amRNSSignificant long term contract win
12th Oct 20167:00 amRNSLong Term Contract with NCHCD
22nd Sep 20167:00 amRNSInterim Results
18th Jul 20167:00 amRNSCrimson Tide selected by large UK retailer
14th Jul 20167:00 amRNSPharmaceutical Verification Pilot
29th Jun 20168:31 amRNSResult of AGM
14th Jun 20167:00 amRNSMpro5 Contract Win
3rd Jun 20163:47 pmRNSFinal Results and Notice of AGM
20th May 20163:26 pmRNSExercise of Options
20th Apr 20167:00 amRNSPreliminary Results
25th Feb 20167:00 amRNSTrading Update
24th Feb 20163:34 pmRNSResult of Court Hearing
26th Jan 20162:37 pmRNSResult of General Meeting
30th Dec 20157:00 amRNSProposed Reconstruction of Capital
4th Dec 20157:00 amRNSUpdate on Significant Contract Win
7th Oct 20155:58 pmRNSHolding(s) in Company
1st Oct 20152:45 pmRNSDirector's Dealing
30th Sep 20157:00 amRNSInterim Results
17th Sep 20157:00 amRNSSignificant contract win
1st Jul 20157:00 amRNSResult of AGM
8th Jun 20157:00 amRNSFinal Results and Notice of AGM
4th Jun 20157:00 amRNSSignificant Contract Win
14th Apr 20157:00 amRNSContracts Update
2nd Apr 20157:00 amRNSPreliminary Results
20th Mar 201510:03 amRNSDirectorate Change
3rd Mar 20157:00 amRNSTrading Update
24th Feb 20157:00 amRNSNew Finance Facilities
30th Jan 20155:02 pmRNSHolding(s) in Company
11th Dec 20147:00 amRNSAppointment of Director
29th Oct 20147:00 amRNSContract win for mpro5
14th Oct 20147:00 amRNSContract win for mpro
23rd Sep 20147:00 amRNSInterim Results
1st Sep 20147:00 amRNSSignificant contract win takes Crimson Tide Global
23rd Jul 20142:28 pmRNSHolding(s) in Company
5th Jun 20144:30 pmRNSDirector's Dealing
4th Jun 20147:00 amRNSContract Extensions for MPRO5 worth over £200k
30th May 20145:35 pmRNSFinal Results and Notice of AGM
10th Apr 20148:56 amRNSHolding(s) in Company
2nd Apr 20147:00 amRNSPreliminary Results
10th Mar 20147:00 amRNSStrategic Partnership Agreement
30th Oct 201311:22 amRNSTR-1: Notification of major interest in shares
29th Oct 20137:00 amRNSContract Extension
20th Sep 20137:05 amRNSNew Contract Wins
20th Sep 20137:00 amRNSInterim Results
17th Sep 20137:00 amRNSContract Extension
23rd Aug 20132:20 pmRNSChange of responsibilities
28th Jun 20133:23 pmRNSResult of AGM
6th Jun 20137:00 amRNSFinal Accounts and AGM
23rd May 20137:00 amRNSThree New Contract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.